PANDEL (PharmaDerm a division of Fougera Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the PANDEL drug offered from PharmaDerm a division of Fougera Pharmaceuticals Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: PharmaDerm a division of Fougera Pharmaceuticals Inc.
NON-PROPRIETARY NAME: HYDROCORTISONE PROBUTATE
SUBSTANCE NAME: HYDROCORTISONE PROBUTATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-02-28
END MARKETING DATE: 0000-00-00


PANDEL HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPANDEL from PharmaDerm a division of Fougera Pharmaceuticals Inc.
LABELER NAME: PharmaDerm a division of Fougera Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/g)
START MARKETING DATE: 1997-02-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10337-153_05460f8a-bc79-428d-a26a-7470df536d3e
PRODUCT NDC: 10337-153
APPLICATION NUMBER: NDA020453

Other HYDROCORTISONE PROBUTATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
PharmaDerm a division of Fougera Pharmaceuticals Inc.PANDEL